475 related articles for article (PubMed ID: 26509555)
41. Factors associated with discordance in the assessment of fibrosis stage between transient elastography and liver biopsy in NAFLD patients.
Lu M; Zhu M; Li H; Wang Q; Qian Y; Wang M; Chen L
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102183. PubMed ID: 37495204
[TBL] [Abstract][Full Text] [Related]
42. Correlates of aortic stiffness progression in patients with resistant hypertension: importance of clinic and ambulatory blood pressure changes.
Roderjan CN; Cardoso CR; Ferreira MT; Muxfeldt ES; Salles GF
J Hypertens; 2015 Apr; 33(4):827-34; discussion 834-5. PubMed ID: 25915888
[TBL] [Abstract][Full Text] [Related]
43. Association between anthropometric parameters and measurements of liver stiffness by transient elastography.
Wong GL; Chan HL; Choi PC; Chan AW; Lo AO; Chim AM; Wong VW
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):295-302.e1-3. PubMed ID: 23022698
[TBL] [Abstract][Full Text] [Related]
44. Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening.
Lomonaco R; Godinez Leiva E; Bril F; Shrestha S; Mansour L; Budd J; Portillo Romero J; Schmidt S; Chang KL; Samraj G; Malaty J; Huber K; Bedossa P; Kalavalapalli S; Marte J; Barb D; Poulton D; Fanous N; Cusi K
Diabetes Care; 2021 Feb; 44(2):399-406. PubMed ID: 33355256
[TBL] [Abstract][Full Text] [Related]
45. Comparison of point-shear wave elastography (ElastPQ) and transient elastography (FibroScan) for liver fibrosis staging in patients with non-alcoholic fatty liver disease.
Roccarina D; Iogna Prat L; Pallini G; Guerrero Misas M; Buzzetti E; Saffioti F; Aricò FM; Mantovani A; Koutli E; Goyale A; Rosselli M; Luong TV; Pinzani M; Tsochatzis EA
Liver Int; 2022 Oct; 42(10):2195-2203. PubMed ID: 35635761
[TBL] [Abstract][Full Text] [Related]
46. Aortic-Brachial Stiffness Mismatch and Mortality in Peritoneal Dialysis Patients.
Bao W; Wang F; Tang W
Kidney Blood Press Res; 2019; 44(1):123-132. PubMed ID: 30808839
[TBL] [Abstract][Full Text] [Related]
47. Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening.
Poustchi H; Alaei-Shahmiri F; Aghili R; Nobarani S; Malek M; Khamseh ME
Arch Iran Med; 2021 Mar; 24(3):177-186. PubMed ID: 33878875
[TBL] [Abstract][Full Text] [Related]
48. Changes in Aortic Pulse Wave Velocity and the Predictors of Improvement in Arterial Stiffness Following Aortic Valve Replacement.
Cantürk E; Çakal B; Karaca O; Omaygenç O; Salihi S; Özyüksel A; Akçevin A
Ann Thorac Cardiovasc Surg; 2017 Oct; 23(5):248-255. PubMed ID: 28890466
[TBL] [Abstract][Full Text] [Related]
49. The impact of warfarin on the rate of progression of aortic stiffness in hemodialysis patients: a longitudinal study.
Mac-Way F; Poulin A; Utescu MS; De Serres SA; Marquis K; Douville P; Desmeules S; Larivière R; Lebel M; Agharazii M
Nephrol Dial Transplant; 2014 Nov; 29(11):2113-20. PubMed ID: 24944209
[TBL] [Abstract][Full Text] [Related]
50. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease.
Alam MS; Kamrul-Hasan ABM; Kalam ST; Rahman SMM; Hoque MI; Islam MB; Paul AK
Diabetes Metab Syndr Obes; 2021; 14():3089-3096. PubMed ID: 34262313
[TBL] [Abstract][Full Text] [Related]
51. A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease.
Casey SP; Kemp WW; McLean CA; Topliss DJ; Adams LA; Roberts SK
Scand J Gastroenterol; 2012 Jul; 47(7):836-41. PubMed ID: 22519948
[TBL] [Abstract][Full Text] [Related]
52. Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness.
Sunbul M; Agirbasli M; Durmus E; Kivrak T; Akin H; Aydin Y; Ergelen R; Yilmaz Y
Atherosclerosis; 2014 Dec; 237(2):490-3. PubMed ID: 25463079
[TBL] [Abstract][Full Text] [Related]
53. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.
Corpechot C; Carrat F; Poujol-Robert A; Gaouar F; Wendum D; Chazouillères O; Poupon R
Hepatology; 2012 Jul; 56(1):198-208. PubMed ID: 22271046
[TBL] [Abstract][Full Text] [Related]
54. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.
Kwok R; Choi KC; Wong GL; Zhang Y; Chan HL; Luk AO; Shu SS; Chan AW; Yeung MW; Chan JC; Kong AP; Wong VW
Gut; 2016 Aug; 65(8):1359-68. PubMed ID: 25873639
[TBL] [Abstract][Full Text] [Related]
55. High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort.
Llop E; Iruzubieta P; Perelló C; Fernández Carrillo C; Cabezas J; Escudero MD; González M; Hernández Conde M; Puchades L; Arias-Loste MT; Serra MÁ; Crespo J; Calleja JL
United European Gastroenterol J; 2021 Oct; 9(8):892-902. PubMed ID: 34077628
[TBL] [Abstract][Full Text] [Related]
56. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning.
Noureddin M; Ntanios F; Malhotra D; Hoover K; Emir B; McLeod E; Alkhouri N
Hepatol Commun; 2022 Jul; 6(7):1537-1548. PubMed ID: 35365931
[TBL] [Abstract][Full Text] [Related]
57. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
58. Identification of patients with type 2 diabetes with non-alcoholic fatty liver disease who are at increased risk of progressing to advanced fibrosis: a cross-sectional study.
Mettananda C; Egodage T; Dantanarayana C; Fernando R; Ranaweera L; Luke N; Ranawaka C; Kottahachchi D; Pathmeswaran A; de Silva HJ; Dassanayake AS
BMJ Open; 2023 Jan; 13(1):e063959. PubMed ID: 36639212
[TBL] [Abstract][Full Text] [Related]
59. Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.
Labenz C; Huber Y; Kalliga E; Nagel M; Ruckes C; Straub BK; Galle PR; Wörns MA; Anstee QM; Schuppan D; Schattenberg JM
Aliment Pharmacol Ther; 2018 Nov; 48(10):1109-1116. PubMed ID: 30288767
[TBL] [Abstract][Full Text] [Related]
60. Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan.
Roulot D; Roudot-Thoraval F; NKontchou G; Kouacou N; Costes JL; Elourimi G; Le Clesiau H; Ziol M; Beaugrand M
Liver Int; 2017 Dec; 37(12):1897-1906. PubMed ID: 28556413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
